> What would a lifelong subscription like this mean for a corporation like Pfizer? Honestly, very little. As an example, 120x 2mg oral estradiol, which is a co

> What would a lifelong subscription like this mean for a corporation like Pfizer? Honestly, very little. As an example, 120x 2mg oral estradiol, which is a common dosage prescribed to both trans women and cis (that is, non-trans) women with endocrine disorders, costs about $35/mo to insurance in my area, which isn't much of a margin. It's also fully genericized, so it's very unlikely that any one manufacturer could profit by pushing that margin up; there's just too much competition. In fact, in the hormone space, the real scandal is vaginally administered estrogens for cisgender women. There have been massive, unjustified price increases in the last decade.